[11C]SY-08

N/A

Report date: 2025/11/28 15:16:18

Base Information

Drug Name[11C]SY-08
Drug Alias NameC11-SY08[11C]SY-08[11C]SY08
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Carbon > 11CDiagnostic agent (In vivo) > Radionuclide Imaging agent +[4] 
Mechanisms of ActionPositron-emission tomography enhancersSynuclein alpha binders
TargetsSynuclein alpha
Therapy Area/IndicationsParkinson DiseaseLewy Body DiseaseMultiple System Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMassachusetts General Hospital
China Registration ClassN/A

Develop Information

Active CompaniesMassachusetts General Hospital
Inactive CompaniesN/A
Active IndicationsParkinson DiseaseLewy Body DiseaseMultiple System Atrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A